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We thank the authors Bos and Veersteg for their insightful commentary[1](#rth212187-bib-0001){ref-type="ref"} on our brief report entitled "Circulating Microvesicles in Snakebite Patients with Microangiopathy" recently published in *Research and Practice in Thrombosis and Haemostasis*.[2](#rth212187-bib-0002){ref-type="ref"} We echo their concern that venom‐induced consumption coagulopathy (VICC) is one of the most medically important envenoming syndromes worldwide, particularly in tropical areas.[3](#rth212187-bib-0003){ref-type="ref"} The activation of the clotting pathway by procoagulant venom toxins produced by many Viperid snakes and certain elapids, including Australian elapids, results in consumption of clotting factors leading to high risk of major hemorrhage in the victims.[4](#rth212187-bib-0004){ref-type="ref"} However, the occurrence of VICC and microangiopathic hemolysis (MAHA) is an unintended complication in human envenoming. In animals, usually meant to be prey for snakes, venom post‐synaptic neurotoxins play a more central role by paralyzing the animal.[5](#rth212187-bib-0005){ref-type="ref"} Hence, in vivo animal models for coagulopathy have been difficult to establish because of differential effect of snake venom on different animal plasma.[5](#rth212187-bib-0005){ref-type="ref"}

MAHA occurs in a smaller proportion of snake bite victims with VICC and is often associated with thrombocytopenia/anemia.[6](#rth212187-bib-0006){ref-type="ref"} The mechanisms of endothelial damage and precise risk for developing MAHA are poorly understood. The results from our study provide, for the first time, the investigation of platelet, red cell, and endothelia‐derived microvesicles (MV) as measured by flow cytometry in the plasma of snake bite patients recruited from the Australian Snakebite Project (ASP). Essentially, in this hypothesis‐generating study, it was observed that red cell MV are significantly higher in snake bite patients with VICC and MAHA when compared to snake bite patients with VICC and *no* MAHA (Figure [1](#rth212187-fig-0001){ref-type="fig"}). The mechanisms for production of MV and red cell fragments are likely very different. We believe that these 200‐ to 1000‐nm MV are distinct from larger red cell fragments of a few microns that have been described from studies using the automated hematology analyzers.[7](#rth212187-bib-0007){ref-type="ref"}, [8](#rth212187-bib-0008){ref-type="ref"} More importantly, a markedly elevated red cell MV level detected by flow cytometry may be used as a surrogate marker for MAHA whereas thrombocytopenia alone may not be able to discriminate between those snakebite patients with evolving MAHA and those without.

![Shows median and 95% confidence intervals, in log scale, for platelet, endothelial and red cell MV between the snakebite patients with VICC (no MAHA) and with VICC + MAHA. The significant *P* values are shown for differences between the groups for one way ANOVA (Kruskal‐Wallis test)](RTH2-3-298-g001){#rth212187-fig-0001}

In spite of the limitations in using flow cytometry, it is easily available and its use in routine diagnostics is widespread. In fact, it is one of the few techniques extensively investigated for measurement of MV and where standardization recommendations have been published from across three workshops by the International Society on Thrombosis and Haemostasis.[9](#rth212187-bib-0009){ref-type="ref"}, [10](#rth212187-bib-0010){ref-type="ref"}, [11](#rth212187-bib-0011){ref-type="ref"} The MV detected by flow cytometry have also been described to be more relevant for coagulant function in human plasma.[12](#rth212187-bib-0012){ref-type="ref"} As technology advances, the availability of bench‐top hematology analyzers with flow‐cytometric capacity in many tropical reference centers is not unforeseeable in the near future.

While our results do not resolve the mechanistic basis of MAHA, the finding of low endothelial MV in snake bite victims is intriguing. In vitro models using endothelial cell culture exposed to snake venom could be one approach to understanding this effect. Measuring leucocyte‐derived MV would be useful in considering the role of snake venom--induced leukocyte damage and its contribution to the coagulopathic process. Serial sampling could provide valuable information on the time course of the pathophysiological events. We also envisage that functional studies would add value to measurement of the red cell, endothelial, and platelet "bubbles" (ie, MV) after envenoming as a segway to understanding the "trouble" (ie, pathophysiological process) underpinning VICC and MAHA.
